VivoPharm Company Profile: Acquisition & Investors

VivoPharm Overview

Founded
2003

Status
Acquired/Merged

Employees
35

Latest Deal Type
Buyout/LBO

Financing Rounds
5

Investments
1

VivoPharm General Information

Description

Provider of proprietary preclinical oncology and immuno-oncology services intended to offer integrated service in different disease areas to the biotechnology and pharmaceutical industries. The company specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug (IND) filing, thereby enabling its clients to get treated in a better way in different disease areas.

Contact Information

Website

www.vivopharm.com.au

Ownership Status

Acquired/Merged
(Operating Subsidiary)

Financing Status

Private Equity-Backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Other Industries

Pharmaceuticals

Parent Company

Reaction Biology

Primary Office

Level 3, 240 Plenty Road, Bundoora
Suite S29
Melbourne, Victoria 3083
Australia

+61 (03) 0000 0000





Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VivoPharm Valuation & Funding

Deal Type	Date	Amount	Valuation/ EBITDA	Post-Val	Status	Debt

This information is available in the PitchBook Platform. To explore VivoPharm‘s full profile, request access.

Request a free trial

VivoPharm Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last
Financing
Details

Provider of proprietary preclinical oncology and immuno-oncology services intended to offer integrated service in differ

Other Pharmaceuticals and Biotechnology

Melbourne, Australia

35 As of 2022

00.00

0.000 0000-00-00

000000000000

000000

ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d

00000 00000000000000

Nashville, TN

00 As of 0000

000000000000

000

iscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

0000 000000000

Warsaw, Poland

000 As of 0000

00000000000

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VivoPharm Competitors (12)

Company Name	Financing Status	Location	Employees	Total Raised	Last Financing Date/Type	Last Financing Amount
Medelis	Private Equity-Backed	Nashville, TN	00		000000000000
000	Formerly PE-Backed	Warsaw, Poland	000		00000000000
0000000 000000000	Formerly VC-backed	Cambridge, United Kingdom	000	00000	000000&0	00000
000 000	Corporation	Zug, Switzerland
0000000	Private Equity-Backed	Ann Arbor, MI	00000		0000000 0000

You’re viewing 5 of 12 competitors. Get the full list »

VivoPharm Patents

3
Total Documents Applications and Grants
000
Total Patents Families
000
Granted
000
Pending
000
Expiring in next 12 mo

VivoPharm Recent Patent Activity

Publication ID	Patent Title	Status	First Filing Date	Technology (CPC)
US-20050214220-A1	Developing orthotopic animal models; quickly and reliably testing antitumor agent efficacy	Inactive	24-Mar-2004	00000000000
AU-2004901532-A0	Tumour model	Inactive	24-Mar-2004
AU-2005201291-A1	Tumour model	Inactive	24-Mar-2004

VivoPharm Executive Team (5)

Name	Title	Board Seat	Contact Info
Sabine Brandt	Co-Founder & Executive Finance & HR Manager
Melanie Keller	Division Head, Europe
Chris Holding	Division Head of Efficacy Testing

You’re viewing 3 of 5 executive team members. Get the full list »

VivoPharm Board Members (3)

Name	Representing	Role
0000000 000000	VivoPharm	Board Member
000 000000 00.0	Self	Chairman
0000 000000 00.0	VivoPharm	Co-Founder & President, Discovery and Early Development